HomeCompareADXSD vs FCPT

ADXSD vs FCPT: Dividend Comparison 2026

ADXSD yields 51.95% · FCPT yields 6.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ADXSD wins by $386.4K in total portfolio value
10 years
ADXSD
ADXSD
● Live price
51.95%
Share price
$3.85
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$435.5K
Annual income
$90,970.08
Full ADXSD calculator →
FCPT
FCPT
● Live price
6.05%
Share price
$23.65
Annual div
$1.43
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.1K
Annual income
$5,775.28
Full FCPT calculator →

Portfolio growth — ADXSD vs FCPT

📍 ADXSD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodADXSDFCPT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ADXSD + FCPT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ADXSD pays
FCPT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ADXSD
Annual income on $10K today (after 15% tax)
$4,415.58/yr
After 10yr DRIP, annual income (after tax)
$77,324.57/yr
FCPT
Annual income on $10K today (after 15% tax)
$514.49/yr
After 10yr DRIP, annual income (after tax)
$4,908.99/yr
At 15% tax rate, ADXSD beats the other by $72,415.58/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ADXSD + FCPT for your $10,000?

ADXSD: 50%FCPT: 50%
100% FCPT50/50100% ADXSD
Portfolio after 10yr
$242.3K
Annual income
$48,372.68/yr
Blended yield
19.97%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

ADXSD
No analyst data
FCPT
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
Price Target
$27.00
+14.2% upside vs current
Range: $25.00 — $29.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ADXSD buys
0
FCPT buys
0
No recent congressional trades found for ADXSD or FCPT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricADXSDFCPT
Forward yield51.95%6.05%
Annual dividend / share$2.00$1.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$435.5K$49.1K
Annual income after 10y$90,970.08$5,775.28
Total dividends collected$350.5K$24.1K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: ADXSD vs FCPT ($10,000, DRIP)

YearADXSD PortfolioADXSD Income/yrFCPT PortfolioFCPT Income/yrGap
1← crossover$15,895$5,194.81$11,401$700.92+$4.5KADXSD
2$24,724$7,716.86$13,064$864.84+$11.7KADXSD
3$37,673$11,218.27$15,051$1,072.48+$22.6KADXSD
4$56,286$15,975.38$17,442$1,337.22+$38.8KADXSD
5$82,532$22,306.57$20,340$1,677.08+$62.2KADXSD
6$118,878$30,568.54$23,880$2,116.57+$95.0KADXSD
7$168,350$41,149.89$28,241$2,689.36+$140.1KADXSD
8$234,596$54,462.14$33,660$3,442.07+$200.9KADXSD
9$321,946$70,928.36$40,456$4,439.95+$281.5KADXSD
10$435,453$90,970.08$49,063$5,775.28+$386.4KADXSD

ADXSD vs FCPT: Complete Analysis 2026

ADXSDStock

Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for the treatment of prostate cancer. It is also conducting clinical studies of Lm Technology immunotherapies in the following areas of disease focused hotspot/off-the-shelf neoantigen-directed therapies; human papilloma virus-associated cancers; and prostate cancer. The company has collaborations and partnerships with Merck & Co., Inc.; OS Therapies, LLC; Aratana Therapeutics Inc.; Biocon Limited; Global BioPharma Inc.; Knight Therapeutics Inc; and others. Advaxis, Inc. was founded in 2002 and is based in Monmouth Junction, New Jersey.

Full ADXSD Calculator →

FCPTREIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →
📬

Get this ADXSD vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ADXSD vs SCHDADXSD vs JEPIADXSD vs OADXSD vs KOADXSD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.